Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

Four weeks after starting Mounjaro, Clare Meadowcroft was hospitalised for 10 days with acute pancreatitis and underwent ...

A MUM thought her weight loss jabs were giving her trapped wind until she was racked by pains “worse than labour”, forcing ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...

SERENA Williams has revealed she used fat jabs to shed pounds after giving birth to her two daughters. The tennis star has ...

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams says “sometimes you need help” as she opens up about weight loss, breaking stigma, and finding balance after ...

I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained,” the tennis legend ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Serena Williams opens up about her weight loss struggles and the use of GLP-1 medications, highlighting issues of access and ...